You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCAness

Showing 1 - 25 of 33
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Salt Lake City (Rucaparib)

Active, not recruiting
  • Prostate Cancer
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Jun 23, 2022

Ovarian Tumors Trial in Rome (Trabectedin, Pegylated Liposomal Doxorubicin, Topotecan)

Completed
  • Ovarian Neoplasms
  • Rome, Italy
    Domenica Lorusso
Aug 24, 2021

Metastatic Breast Cancer Trial in Lyon, Marseille (rucaparib)

Completed
  • Metastatic Breast Cancer
  • Lyon, France
  • +1 more
Jun 5, 2021

Ovarian Tumor Epithelial, Homologous Recombination Deficiency, BRCA1 Mutation Trial in Groningen, Leiden, Rotterdam (Functional

Recruiting
  • Ovarian Neoplasm Epithelial
  • +3 more
  • Functional RAD51 assay
  • Olaparib Oral Product
  • Groningen, Netherlands
  • +2 more
Mar 30, 2021

Metastatic Pancreatic Adenocarcinoma Trial in France (Arm A - Olaparib, ARM B - durvalumab plus selumetinib, ARM C FOLFIRI)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Arm A - Olaparib
  • +2 more
  • Avignon, France
  • +28 more
Dec 29, 2020

TNBC - Triple-Negative Breast Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (olaparib, Durvalumab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • +2 more
  • (no location specified)
Jan 12, 2022

Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone Trial in Shanghai (Camrelizumab and fluzoparib with concurrent stereotactic body

Recruiting
  • Sarcoma
  • +2 more
  • Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT)
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
Oct 3, 2023

Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)

Not yet recruiting
  • Breast Cancer
  • Marseille, France
    Institut Paoli Calmettes
Aug 9, 2023

Glioblastoma Trial in Philadelphia (18F-FluorThanatrace)

Recruiting
  • Glioblastoma
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Jan 21, 2022

Metastatic Esophageal Carcinoma, Metastatic Gastric Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma Trial in

Active, not recruiting
  • Metastatic Esophageal Carcinoma
  • +12 more
  • Corona, California
  • +31 more
Aug 9, 2022

Recurrent Glioma, Recurrent Glioblastoma, Poly ADP Ribose Polymerase (PARP) Inhibitor Trial in Hong Kong (Talazoparib)

Recruiting
  • Recurrent Glioma
  • +4 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Aug 19, 2021

Metastatic BRCA-Associated Breast Carcinoma, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Brain Trial in

Active, not recruiting
  • Metastatic BRCA-Associated Breast Carcinoma
  • +5 more
  • Anchorage, Alaska
  • +815 more
Aug 5, 2022

Homologous Recombination Repair Pathway Gene Mutation Spectrum

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jun 4, 2023

    Endometrial Cancer, Papillary Serous Endometrial Carcinoma, Uterine Serous Carcinoma Trial in United States (Niraparib)

    Recruiting
    • Endometrial Cancer
    • +4 more
    • New Brunswick, New Jersey
    • +4 more
    Mar 17, 2022

    Triple Negative Breast Cancer Trial in Dhaka (Doxorubicin, Cyclophosphamide, Paclitaxel)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    May 24, 2023

    Efficacy and Safety Trial in Zhejiang (Arsenic trioxide Tablet +Fuzuloparib Capsules)

    Recruiting
    • Efficacy and Safety
    • Arsenic trioxide Tablet +Fuzuloparib Capsules
    • Zhejiang, Hangzhou, China
      Women's Hospital School Of Medicine Zhejiang University
    Jan 23, 2022

    Metastatic Melanoma Trial in San Francisco (Niraparib)

    Recruiting
    • Metastatic Melanoma
    • San Francisco, California
      California Pacific Medical Center Research Institute
    Oct 15, 2021

    Prevalence of BRCA in Patients With Ovarian Cancer

    Completed
    • BRCA Status
    • Ovarian Cancer
    • Testing of BRCA status regarding germline and somatic mutation
    • Berlin, Germany
    • +19 more
    Jun 11, 2021

    Tumors Trial in France, Spain, United Kingdom (Niraparib, Dostarlimab)

    Recruiting
    • Neoplasms
    • Brno, Czechia
    • +20 more
    Nov 21, 2022

    Glioblastoma, Recurrent Glioblastoma, GBM Trial in Philadelphia (drug, device, procedure)

    Recruiting
    • Glioblastoma
    • +2 more
    • Philadelphia, Pennsylvania
      Hospital of the University of Pennsylvania
    Jul 16, 2021

    Metastatic Melanoma Trial in San Francisco (Olaparib, Pembrolizumab)

    Recruiting
    • Metastatic Melanoma
    • San Francisco, California
      California Pacific Medical Center Research Institute
    Apr 30, 2021

    Triple-negative Breast Cancer Trial in Milano (Fasting-mimicking diet, Metformin, Preoperative chemo)

    Active, not recruiting
    • Triple-negative Breast Cancer
    • Fasting-mimicking diet
    • +2 more
    • Milano, Italy
      Fondazione IRCCS Istituto Nazionale Tumori
    Jan 17, 2023

    Prostate Cancer Trial in New York (Satraplatin)

    Completed
    Has Results
    • Prostate Cancer
    • New York, New York
      Mount Sinai Medical Center
    Jan 16, 2018

    Breast Cancer Trial in Greenville (drug, procedure, radiation)

    Terminated
    Has Results
    • Breast Cancer
    • Doxorubicin / Cyclophosphamide / Paclitaxel / Carboplatin
    • +2 more
    • Greenville, North Carolina
      Brody School of Medicine at East Carolina University
    May 4, 2021

    HER2-negative Breast Cancer Trial in Chengdu (AT regimen, TP regimen)

    Unknown status
    • HER2-negative Breast Cancer
    • AT regimen
    • TP regimen
    • Chengdu, Sichuan, China
      Department of breast surgery, Sichuan Provincial People's Hospit
    Jul 30, 2020